Saturday, July 5, 2025 7/5/2025

Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis

Award Number: R01DK117138
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/15/2019
PERIOD OF PERFORMANCE END DATE: 12/31/2023

Group Awards By:

View Award Description

Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis - Project Summary The current project proposes an original framework to translate basic mouse immunology of the pre-clinical phase of type 1 diabetes (T1D) to human, using sophisticated single cell technologies. Over the past four years, we have dissected the antigen-specific CD4+ T cell response in the NOD mouse model using single cell gene profiling, TCR sequencing, and RNAseq to understand the process of activation of autoreactive T cells in target organs. After defining a unique program of activation for islet-specific CD4+ T cells, we isolated the same cells from peripheral blood of pre-diabetic mice. Our contention is that similar studies can now be done in human and help diagnose disease at a very early stage and follow disease evolution and monitor therapeutic intervention. In addition, the same approach will deliver important mechanistic insights in the role of CD4+ T cells in T1D onset and progression. Our work will be focused on two specific aims: SA #1: Expand the mouse studies to optimize their translational value. In the NOD mouse model, single cell analysis of islet CD4+ T cells has allowed the identification of recirculating autoreactive CD4+ T cells in the peripheral blood. Probing two antigen specificities with a series of pMHC tetramers, the profile of pathogenic cells was dissected by gene expression profiling, RNAseq, and TCR αβ pair sequencing. Using the same approach, further characterization of these cells will allow us to gain mechanistic insights and identify potential new therapeutic targets. We hypothesize that recirculating T cells from all stages of the disease process can be found in blood and analyzed by single cell technologies, and used to diagnose and follow disease evolution. SA #2: Analysis of activated CD4+ T cells from the peripheral blood of T1D patients. Using the same approaches and single cell technology, we will characterize a circulating CD4+HLA-DR+PD-1+CXCR3+ cell population that we have identified in T1D patients and not in controls. Antigen specificity will be examined using HLA-DQ tetramers, and functionally using T cell activation assays after TCR re-expression of sequenced αβ pairs as well as new humanized mouse models. A single antigen, insulin, and common mouse-human epitopes will be used for this translation before additional antigen reactivities are examined. The approach will be tested for its ability to measure the anti-islet autoreactivity in “at-risk”, “just-diagnosed”, and “established” T1D patients, and compared to the classic anti-islet antibody detection. The two aims will also evaluate the precise role of the “P9 switch” mode of T cell recognition in mice and human T1D, respectively, and potentially answer why this disease is linked to the single HLA class II β57 polymorphism. Hopefully, we will demonstrate that single cell technologies by interrogating rare cells in peripheral blood, have the power to diagnose T1D in its pre-clinical phase in at risk patients. Such a revolutionary approach would permit to monitor evolution and new therapies aimed at maintaining β cell mass.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	SCRIPPS RESEARCH INSTITUTE	10550 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	4	5/7/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $788,462 )
2022	2022	SCRIPPS RESEARCH INSTITUTE, THE	10550 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	4	3/24/2022	NON-COMPETING CONTINUATION	$78,849
2022	2022	SCRIPPS RESEARCH INSTITUTE, THE	10550 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	4	2/21/2022	NON-COMPETING CONTINUATION	$709,613
														Subtotal = $788,462

Issue Date FY: 2021 ( Subtotal = $788,774 )
2021	2021	SCRIPPS RESEARCH INSTITUTE, THE	10550 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	3/2/2021	NON-COMPETING CONTINUATION	$788,774
														Subtotal = $788,774

Issue Date FY: 2020 ( Subtotal = $789,010 )
2020	2020	SCRIPPS RESEARCH INSTITUTE, THE	10550 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	4/15/2020	NON-COMPETING CONTINUATION	$789,010
														Subtotal = $789,010

Issue Date FY: 2019 ( Subtotal = $812,694 )
2019	2019	SCRIPPS RESEARCH INSTITUTE, THE	10550 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	3/4/2019	NEW	$812,694
														Subtotal = $812,694

Grand Total All Awards = $3,178,940

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis

Award Number: R01DK117138

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/15/2019

PERIOD OF PERFORMANCE END DATE: 12/31/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer